Jon Hartas - Concepedia

Author

Jon Hartas

QIMR Berghofer Medical Research Institute

Also Known As

J Hartas, J. HARTAS, J. Hartas, JON HARTAS, Jon Hartas

Publications

890

Citations

H-Index

Concepts

All Affiliations

QIMR Berghofer Medical Research Institute Menzies School of Health Research Griffith University The University of Queensland The University of Melbourne

About

Jon Hartas is an author at QIMR Berghofer Medical Research Institute specializing in medicine, microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	488
2	Natural Sciences	2	2	90
3	Allergy	2	2	91
4	Engineering	1	1	32
5	Health Sciences	1	1	13

Jon Hartas

Publications

882

Citations

H-Index

Page 1

	Year	Citations
Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial Silvana Sekuloski, Michael R. Batzloff, Paul Griffin, PLoS ONE	2018	82
Vir typing: a long-PCR typing method for group A streptococci. Don L. Gardiner, Jon Hartas, Bart J. Currie, Genome Research	1995	81
Intranasal Vaccination with a Lipopeptide Containing a Conformationally Constrained Conserved Minimal Peptide, a Universal T Cell Epitope, and a Self‐Adjuvanting Lipid Protects Mice from Group A Streptococcus Challenge and Reduces Throat Colonization Michael R. Batzloff, Jon Hartas, Weiguang Zeng, The Journal of Infectious Diseases Microbial PathogensImmunologyImmunodominanceImmunologic MechanismAntigen Processing	2006	73
Conserved anchorless surface proteins as group A streptococcal vaccine candidates Anna Henningham, Emiliano Chiarot, Christine M. Gillen, Journal of Molecular Medicine VaccinationVaccine DevelopmentMedicineVaccine TargetPathogenesis	2012	61
A Synthetic M Protein Peptide Synergizes with a CXC Chemokine Protease To Induce Vaccine-Mediated Protection against Virulent Streptococcal Pyoderma and Bacteremia Manisha Pandey, Emma L. Langshaw, Jon Hartas, The Journal of Immunology Combination VaccineImmunologyVaccine TargetInfection ControlVirulent Streptococcal Pyoderma	2015	57
Toward the Development of an Antidisease, Transmission‐Blocking Intranasal Vaccine for Group A Streptococcus Michael R. Batzloff, Huaru Yan, Mark R. Davies, The Journal of Infectious Diseases	2005	52
Lateral genetic transfers between group A and G streptococci for M-like genes are ongoing Kadaba S. Sriprakash, Jon Hartas Microbial Pathogenesis M-like GenesMedical MicrobiologyAntimicrobial Resistance GeneGroup AGenetics	1996	50
Streptococcus pyogenesstrains containingemm12 andemm55 possess a novel gene coding for distantly related SIC protein Jon Hartas, Kadaba S. Sriprakash Microbial Pathogenesis Novel GeneNatural SciencesGeneticsPathogenesisMolecular Biology	1999	47
Long-Term Antibody Memory Induced by Synthetic Peptide Vaccination Is Protective against <i>Streptococcus pyogenes</i> Infection and Is Independent of Memory T Cell Help Manisha Pandey, Michelle Wykes, Jon Hartas, The Journal of Immunology	2013	47
Polymer–Peptide Hybrids as A Highly Immunogenic Single-Dose Nanovaccine Abdullah AH Ahmad Fuaad, Zhongfan Jia, Mehfuz Zaman, Nanomedicine	2013	47

Page 1